Circadian variation within hemostasis: An underrecognized link between biology and disease?

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 1, 2009, Pages 23-33

  Montagnana, Martina ^a   Salvagno, Gian Luca ^a   Lippi, Giuseppe ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Biological variability; Circadian variability; Coagulation; Fibrinolysis; Hemostasis

Indexed keywords

BLOOD CLOTTING INHIBITOR; PROCOAGULANT;

BLEEDING; CARDIOVASCULAR DISEASE; CELL DIVISION; CELL FUNCTION; CELL GROWTH; CIRCADIAN RHYTHM; CLINICAL STUDY; DISEASE SEVERITY; ENDOTHELIUM; ENVIRONMENTAL STRESS; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INFORMATION PROCESSING; OSCILLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BLOOD COAGULATION; CIRCADIAN RHYTHM; ENDOTHELIUM, VASCULAR; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEMOSTASIS; HUMANS; THROMBOSIS;

EID: 63149129183     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1214145     Document Type: Review

References (116)

1. Reilly DF, Westgate EJ, FitzGerald GA. Peripheral circadian clocks in the vasculature. Arterioscler Thromb Vasc Biol 2007;27:1694-1705
2. Lin JD, Liu C, Li S. Integration of energy metabolism and the mammalian clock. Cell Cycle 2008;7:453-457
3. Barnard AR, Nolan PM. When clocks go bad: neurobehavioural consequences of disrupted circadian timing. PLoS Genet 2008;4:e1000040
4. Harrisingh MC, Nitabach MN. Circadian rhythms. Integrating circadian timekeeping with cellular physiology. Science 2008;320:879-880
5. Maemura K, Takeda N, Nagai R. Circadian rhythms in the CNS and peripheral clock disorders: role of the biological clock in cardiovascular diseases. J Pharmacol Sci 2007;103: 134-138
6. Guo YF, Stein PK. Circadian rhythm in the cardiovascular system: chronocardiology. Am Heart J 2003;145:779-786
7. Buijs RM, Kalsbeek A. Hypothalamic integration of central and peripheral clocks. Nat Rev Neurosci 2001;2:521-526
8. Morse D, Sassone-Corsi P. Time after time: inputs to and outputs from the mammalian circadian oscillators. Trends Neurosci 2002;25:632-637
9. Stephan FK, Zucker I. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci U S A 1972;69:1583-1586
10. Silver R, Lesauter J. Circadian and homeostatic factors in arousal. Ann N Y Acad Sci 2008;1129:263-274
11. Hastings M, O'Neill JS, Maywood ES. Circadian clocks: regulators of endocrine and metabolic rhythms. J Endocrinol 2007;195:187-198
12. Portaluppi F, Lemmer B. Chronobiology and chronotherapy of ischemic heart disease. Adv Drug Deliv Rev 2007;59:952-965
13. Tofler GH, Muller JE. Triggering of acute cardiovascular disease and potential preventive strategies. Circulation 2006;114:1863-1872
14. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-1322
15. Kapiotis S, Jilma B, Quehenberger P, Ruzicka K, Handler S, Speiser W. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex. Circulation 1997;96:19-21
16. Feng DL, Tofler GH. Diurnal physiologic processes and circadian variation of acute myocardial infarction. J Cardiovasc Risk 1995;2:494-498
17. Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 1971;33:14-22
18. Muller JE. Circadian variation and triggering of acute coronary events. Am Heart J 1999;137:S1-S8
19. Fujita M, Franklin D. Diurnal changes in coronary blood flow in conscious dogs. Circulation 1987;76:488-491
20. Turton MB, Deegan T. Circadian variations of plasma catecholamine, cortisol, and immunoreactive insulin concentrations in supine subjects. Clin Chim Acta 1974;55:389-397
21. Decousus HA, Croze M, Levi FA, et al. Circadian changes in anticoagulant effect of heparin infused at a constant rate. Br Med J (Clin Res Ed) 1985;290:341-344
22. Pinotti M, Bertolucci C, Portaluppi F, et al. Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler Thromb Vasc Biol 2005;25:646-649
23. Bilora F, Manfredini R, Petrobelli F, Vettore G, Boccioletti V, Pomerri F. Chronobiology of non fatal pulmonary thromboembolism. Panminerva Med 2001;43:7-10
24. Manfredini R, Boari B, Smolensky MH, et al. Circadian variation in stroke onset: identical temporal pattern in ischemic and hemorrhagic events. Chronobiol Int 2005;22:417-453
25. Casetta I, Granieri E, Portaluppi F, Manfredini R. Circadian variability in hemorrhagic stroke. JAMA 2002;287:1266-1267
26. Gallerani M, Portaluppi F, Maida G, et al. Circadian and circannual rhythmicity in the occurrence of subarachnoid hemorrhage. Stroke 1996;27:1793-1797
27. Manfredini R, Portaluppi F, Zamboni P, Salmi R, Gallerani M. Circadian variation in spontaneous rupture of abdominal aorta. Lancet 1999;353:643-644
28. Arntz HR, Willich SN, Schreiber C, Brüggemann T, Stern R, Schultheiss HP. Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. Eur Heart J 2000;21:315-320
29. Entrican JH, Douglas AS. Circannual rhythm of arterial and venous thromboembolic disease. Scott Med J 1979;24:273-278
30. Lemmer B. Circadian rhythm regulations of the cardiovascular system. Studies in rats and mice. IEEE Eng Med Biol Mag 2007;26:30-32
31. Hjalmarson A, Gilpin E, Nicod P, et al. Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction. Circulation 1989;80:267-275
32. Ridker PM, Manson JAE, Buring JE, Muller JE, Hennekens CH. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation 1990;82:897-902
33. Willich SN, Linderer T, Wegscheider K, Leizorovicz A, Alamercery I, Schroder R, ISAM Study Group. Increased morning incidence of myocardial infarction in the ISAM study: absence with prior b-adrenergic blockade. Circulation 1989;80:853-858
34. Haus E. Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention. Adv Drug Deliv Rev 2007;59:966-984
35. Kornmann B, Schaad O, Reinke H, Saini C, Schibler U. Regulation of circadian gene expression in liver by systemic signals and hepatocyte oscillators. Cold Spring Harb Symp Quant Biol 2007;72:319-330
36. Westgate EJ, Cheng Y, Reilly DF, et al. Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation 2008;117:2087-2095
37. Hartley PS, John Sheward W, French K, Horn JM, Holmes MC, Harmar AJ. Food-entrained rhythmic expression of PER2 and BMAL1 in murine megakaryocytes does not correlate with circadian rhythms in megakaryopoiesis. J Thromb Haemost 2008;6:1144-1152
38. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733-743
39. Braunwald E. Morning resistance to thrombolytic therapy. Circulation 1995;91:1604-1606
40. Undar L, Ertuǧrul C, Altunba H, Akça S. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6. Thromb Haemost 1999;81:571-575
41. Jafri SM, VanRollins M, Ozawa T, Mammen EF, Goldberg AD, Goldstein S. Circadian variation in platelet function in healthy volunteers. Am J Cardiol 1992;69:951-954
42. Numminen H, Syrjälä M, Benthin G, Kaste M, Hillbom M. The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. Stroke 2000;31:1269-1273
43. Bremner WF, Sothern RB, Kanabrocki EL, et al. Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J 2000;139:164-173
44. Jones AR, Twedt D, Swaim W, Gottfried E. Diurnal change of blood count analytes in normal subjects. Am J Clin Pathol 1996;106:723-727
45. Guagnano MT, Davi G, Sensi S. Morning sudden cardiac death. Int J Immunopathol Pharmacol 2000;13:55-60
46. Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316:1514-1518
47. Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol 1992;70:65-68
48. Willich SN, Maclure M, Mittelmann M, Arntz HR, Muller JE. Sudden cardiac death: support for a role of triggering in causation. Circulation 1993;87:1442-1450
49. Undar L, Akkoc N, Alakavuklar MN, Cehreli C, Undar L. Flow cytometric analysis of circadian changes in platelet activation using anti-GMP-140 monoclonal antibody. Chronobiol Int 1999;16:335-342
50. Osmancik P, Kvasnicka J, Widimsky P, Tarnok A. Diurnal variation of soluble E- and P-selectin, and intercellular adhesion molecule-1 in patients with and without coronary artery disease. Cardiology 2004;102:194-199
51. Opper C, Weiner N, Xü F, Adam W, Fruhstorfer H, Wesemann W. Daily variations of functional parameters and density distribution in human blood platelets. Chronobiol Int 1994;11:309-319
52. Wiens L, Lutze G, Luley C, Westphal S. Platelet count and platelet activation: impact of a fat meal and day time. Platelets 2007;18:171-173
53. Dalby MC, Davidson SJ, Burman JF, Davies SW. Diurnal variation in platelet aggregation with the PFA-100 platelet function analyser. Platelets 2000;11:320-324
54. Tengattini S, Reiter RJ, Tan DX, Terron MP, Rodella LF, Rezzani R. Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008;44:16-25
55. Vacas MI, Del Zar MM, Martinuzzo M, Cardinali DP. Binding sites for [3H]-melatonin in human platelets. J Pineal Res 1992;13:60-65
56. Champier J, Claustrat B, Besancon R, et al. Evidence for tryptophan hydroxylase and hydroxy-indol-O-methyltransferase mRNAs in human blood platelets. Life Sci 1997;60:2191-2197
57. Di Bella L, Gualano L. Key aspects of melatonin physiology: thirty years of research. Neuroendocrinol Lett 2006;27:425-432
58. Vacas MI, Del Zar MM, Martinuzzo M, Falcon C, Carreras LO, Cardinali DP. Inhibition of human platelet aggregation and thromboxane B2 production by melatonin. Correlation with plasma melatonin levels. J Pineal Res 1991;11:135-139
59. Cardinali DP, Del Zar MM, Vacas MI. The effects of melatonin in human platelets. Acta Physiol Pharmacol Ther Latinoam 1993;43:1-13
60. Jones SB, Bylund DB, Rieser CA, Shekim WO, Byer JA, Carr GW. Alpha 2-adrenergic receptor binding in human platelets: alterations during the menstrual cycle. Clin Pharmacol Ther 1983;34:90-96
61. Jespersen J, Ingeberg S, Bach E. Antithrombin III and platelets during the normal menstrual cycle and in women receiving oral contraceptives low in oestrogen. Gynecol Obstet Invest 1983;15:153-162
62. Madden LA, Vince RV, Sandström ME, Taylor L, McNaughton L, Laden G. Microparticle-associated vascular adhesion molecule-1 and tissue factor follow a circadian rhythm in healthy human subjects. Thromb Haemost 2008;99:909-915
63. Morel O, Toti F, Hugel B, et al. Procoagulant microparticles - disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006;26:2594-2604
64. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967;13:269-288
65. Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999;104:93-102
66. Omoto S, Nomura S, Shouzu A, Nishikawa M, Fukuhara S, Iwasaka T. Detection of monocyte-derived microparticles in patients with type II diabetes mellitus. Diabetologia 2002;45:550-555
67. Pattanapanyasat K, Noulsri E, Fucharoen S, et al. Flow cytometric quantitation of red blood cell vesicles in thalassemia. Cytometry B Clin Cytom 2004;57B:23-31
68. Etsuda H, Takase B, Uehata A, et al. Morning attenuation of endothelium-dependent, flow-mediated dilation in healthy young men: possible connection to morning peak of cardiac events? Clin Cardiol 1999;22:417-421
69. Gaenzer H, Sturm W, Kirchmair R, Neumayr G, Ritsch A, Patsch J. Circadian variation of endothelium-dependent vasodilatation of the brachial artery as a confounding factor in the evaluation of endothelial function. Atherosclerosis 2000;149:227-228
70. Ringqvist A, Caidahl K, Petersson AS, Wennmalm A. Diurnal variation of flow-mediated vasodilation in healthy premenopausal women. Am J Physiol Heart Circ Physiol 2000;279:H2720-H2725
71. Otto ME, Svatikova A, Barretto RB, et al. Early morning attenuation of endothelial function in healthy humans. Circulation 2004;109:2507-2510
72. Tamura EK, Silva CL, Markus RP. Melatonin inhibits endothelial nitric oxide production in vitro. J Pineal Res 2006;41:267-274
73. Parra DA, Lim DS, Buller CL, Charpie JR. Endothelial dysfunction and circadian blood pressure rhythmicity in young heart transplant recipients. Pediatr Cardiol 2007;28:1-7
74. Müller-Schweinitzer E, Gilles H, Grapow M, Kern T, Reineke D, Zerkowski HR. Attenuation of lipopolysaccharide-induced hyperreactivity of human internal mammary arteries by melatonin. J Pineal Res 2004;37:92-97
75. Järvisalo MJ, Jartti L, Marniemi J, et al. Determinants of short-term variation in arterial flow-mediated dilatation in healthy young men. Clin Sci (Lond) 2006;110:475-482
76. Hijmering ML, Stroes ES, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol 2002;39:683-688
77. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115
78. Maruo T, Nakatani S, Kanzaki H, et al. Circadian variation of endothelial function in idiopathic dilated cardiomyopathy. Am J Cardiol 2006;97:699-702
79. Walters JF, Hampton SM, Deanfield JE, Donald AE, Skene DJ, Ferns GA. Circadian variation in endothelial function is attenuated in postmenopausal women. Maturitas 2006;54:294-303
80. el-Tamimi H, Mansour M, Pepine CJ, Wargovich TJ, Chen H. Circadian variation in coronary tone in patients with stable angina. Protective role of the endothelium. Circulation 1995;92:3201-3205
81. Dart AM, Chin-Dusting JP. Lipids and the endothelium. Cardiovasc Res 1999;43:308-322
82. Lewis TV, Dart AM, Chin-Dusting JP. Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol. J Am Coll Cardiol 1999;33:805-812
83. Mayer GA. Diurnal, postural and postprandial variations of hematocrit. Can Med Assoc J 1965;93:1006-1008
84. Maemura K, de la Monte SM, Chin MT, et al. CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J Biol Chem 2000;275:36847-36851
85. Maemura K, Layne MD, Watanabe M, Perrell MA, Nagai R, Lee ME. Molecular mechanisms of morning onset of myocardial infarction. Ann N Y Acad Sci 2001;947:398-402
86. Viswambharan H, Carvas JM, Antic V, et al. Mutation of the circadian clock gene Per2 alters vascular endothelial function. Circulation 2007;115:2188-2195
87. Haus E, Cusulos M, Sackett-Lundeen L, Swoyer J. Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects. Chronobiol Int 1990;7:203-216
88. Bertolucci C, Pinotti M, Colognesi I, Foà A, Bernardi F, Portaluppi F. Circadian rhythms in mouse blood coagulation. J Biol Rhythms 2005;20:219-224
89. Bertolucci C, Cavallari N, Colognesi I, et al. Evidence for an overlapping role of CLOCK and NPAS2 transcription factors in liver circadian oscillators. Mol Cell Biol 2008;28:3070-3075
90. Kapur R, Hoffman CJ, Bhushan V, Haltin MB. Post-prandial elevation of activated factor VII in young adults. Arterioscler Thromb Vasc Biol 1996;16:1327-1332
91. Tracy RP. Diet and hemostatic factors. Curr Atheroscler Rep 1999;1:243-248
92. Kobayashi H, Oishi K, Hanai S, Ishida N. Effect of feeding on peripheral circadian rhythms and behaviour in mammals. Genes Cells 2004;9:857-864
93. Cooper DN, Millar DS, Wacey A, Banner DW, Tuddenham EG. Inherited factor VII deficiency: molecular genetics and pathophysiology. Thromb Haemost 1997;78:151-160
94. Iversen PO, Groot PD, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM. Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia. Br J Haematol 2002;119:1011-1016
95. Bridges AB, McLaren M, Scott NA, Pringle TH, McNeill GP, Belch JJ. Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. Br Heart J 1993;69:121-124
96. Bridges AB, McLaren M, Saniabadi A, Fisher TC, Belch JJ. Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers. Blood Coagul Fibrinolysis 1991;2:447-452
97. Blombäck M, Konkle BA, Manco-Johnson MJ, Bremme K, Hellgren M, Kaaja R; ISTH SSC Subcommittee on Women's Health Issues. Preanalytical conditions that affect coagulation testing, including hormonal status and therapy. J Thromb Haemost 2007;5:855-858
98. Rudnicka AR, Rumley A, Lowe GD, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 2007;115:996-1003
99. Favaloro EJ. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review. Semin Thromb Hemost 2006;32:537-545
100. Ohkura N, Oishi K, Fukushima N, et al. Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression. J Thromb Haemost 2006;4:2478-2485
101. Akiyama Y, Kazama M, Tahara C, et al. Reference values of hemostasis related factors of healthy Japanese adults. I: circadian fluctuation. Thromb Res 1990;60:281-289
102. Hermida RC, Calvo C, Ayala DE, et al. Seasonal variation of fibrinogen in dipper and nondipper hypertensive patients. Circulation 2003;108:1101-1106
103. Crawford VL, McNerlan SE, Stout RW. Seasonal changes in platelets, fibrinogen and factor VII in elderly people. Age Ageing 2003;32:661-665
104. Folsom AR, Wu KK, Conlan MG, et al. Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. Ethn Dis 1992;2:35-46
105. Kouides PA. Current understanding of von Willebrand's disease in women - some answers, more questions. Haemophilia 2006;12(Suppl 3):143-151
106. Kouides PA. Aspects of the laboratory identification of von Willebrand disease in women. Semin Thromb Hemost 2006;32:480-484
107. Lethagen S, Hillarp A, Ekholm C, Mattson E, Halldén C, Friberg B. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes. Thromb Haemost 2008;99:1013-1038
108. Pasqualetti P, Festuccia V, Acitelli P, Natali L, Collacciani A, Casale R. Circadian rhythms of fibrinogen antithrombin III and plasminogen in chronic liver diseases of increasing severity. Haemostasis 1997;27:140-148
109. Chong NW, Codd V, Chan D, Samani NJ. Circadian clock genes cause activation of the human PAI-1 gene promoter with 4G/5G allelic preference. FEBS Lett 2006;580:4469-4472
110. Fearnley GR, Balmforth G, Fearnley E. Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clin Sci 1957;16:645-650
111. Rosing DR, Brakman P, Redwood DR, et al. Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise. Circ Res 1970;27:171-184
112. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989;79:101-106
113. Kurnik PB. Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation 1995;91:1341-1346
114. Ogawa H, Yasue H, Oshima S, Okumura K, Matsuyama K, Obata K. Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation 1989;80:1617-1626
115. Del Zar MM, Martinuzzo M, Falcón C, Cardinali DP, Carreras LO, Vacas MI. Inhibition of human platelet aggregation and thromboxane-B2 production by melatonin: evidence for a diurnal variation. J Clin Endocrinol Metab 1990;70:246-251
116. Trifiletti A, Bartolone S, Scamardi R, et al. Evaluation of haemostatic parameters and circadian variations of the haemostatic system in patients with systemic sclerosis and Raynaud's phenomenon. Panminerva Med 2000;42:7-9